American Society of Plastic Surgeons welcomes Allergan as Platinum Sponsor of Plastic Surgery The Meeting


Arlington Heights, IL, Aug. 16, 2017 (GLOBE NEWSWIRE) -- The American Society of Plastic Surgeons (ASPS) is proud to recognize Allergan as a Platinum Level sponsor of Plastic Surgery The Meeting. Bringing together the best and brightest surgeons in the specialty, Plastic Surgery The Meeting is a platform for the world’s largest gathering of plastic and reconstructive surgeons to share their expertise with colleagues from nearly 50 nations. It is the leading educational and networking event of the year for both plastic surgeons in the United States and around the globe.

"Allergan is a valued partner in developing and manufacturing pharmaceuticals, medical devices, and biologic and tissue products for patients around the world,” said Debra Johnson, MD, president of the American Society of Plastic Surgeons. “We share a commitment to improving the quality of surgical outcomes and safety through physician and patient education and technological innovation.”

The ASPS Premier Support program provides industry partners with increased visibility and greater recognition for their support at Plastic Surgery The Meeting. Partnering with ASPS provides unprecedented opportunities to communicate and engage with aesthetic and reconstructive plastic surgeons from around the world.

“Our commitment to plastic surgery has never been greater as evidenced by our recent acquisitions of LifeCell, Zeltiq and Keller Medical. Allergan now offers one of the broadest portfolios of best-in-class technologies for plastic surgery and regenerative medicine,” said David Moatazedi, Senior Vice President, Allergan Medical. “Sponsoring Plastic Surgery The Meeting, which is known for its emphasis on education and improving patient outcomes, further demonstrates our commitment to excellence in plastic surgery.”

For more information, visit our Plastic Surgery The Meeting website.

About Allergan
Allergan plc, headquartered in Dublin, Ireland, is a bold, global pharmaceutical company and a leader in a new industry model – Growth Pharma.  Allergan is focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.

Allergan markets a portfolio of leading brands and best-in-class products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology and anti-infective therapeutic categories.

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f1c867f0-26a2-4a2c-bebf-7e643dca12ad


            

Coordonnées